KidneyX Phase 1 Receives 165 Funding Applications

The KidneyX partnership between HHS and the American Society of Nephrology asked for ways to replace kidney function and boost quality of life. Up to 15 Phase 1 awards of $75,000 for the best prototypes are expected, followed three $500,000 Phase 2 awards.

Read the full article » | Posted 04-11-2019

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026